Taiko Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	958	565	-3,563	-4,869	-8,887
Depreciation & Amortization	265	256	704	737	941
Loss (Gain) From Sale of Assets	26	240	2,430	98	2,456
Loss (Gain) From Sale of Investments	-347	-6	-193	76	-60
Other Operating Activities	-2	171	-602	-1,101	-1,023
Change in Accounts Receivable	-23	-411	-175	2,315	3,899
Change in Inventory	57	-301	581	1,257	3,222
Change in Accounts Payable	31	-150	308	-1,177	-2,932
Change in Other Net Operating Assets	-151	-2	203	670	789
Operating Cash Flow	814	362	-307	-1,994	-1,595
Operating Cash Flow Growth	124.86%	-	-	-	-
Capital Expenditures	-291	-157	-97	-64	-1,476
Sale of Property, Plant & Equipment	-	-	170	2	-
Cash Acquisitions	-	-	-	-9	-107
Sale (Purchase) of Intangibles	-13	-30	-17	-20	-124
Investment in Securities	447	266	1,105	283	85
Other Investing Activities	-1	-84	5	-2	-
Investing Cash Flow	142	-5	1,166	190	-1,622
Long-Term Debt Issued	-	-	500	-	5,000
Long-Term Debt Repaid	-1,206	-1,206	-1,053	-923	-316
Net Debt Issued (Repaid)	-1,206	-1,206	-553	-923	4,684
Issuance of Common Stock	-	59	2,132	-	101
Common Dividends Paid	-	-1	-1	-	-782
Other Financing Activities	-21	-33	-39	-74	-44
Financing Cash Flow	-1,227	-1,181	1,539	-997	3,959
Foreign Exchange Rate Adjustments	-5	112	49	76	82
Miscellaneous Cash Flow Adjustments	1	-	-	1	-1
Net Cash Flow	-275	-712	2,447	-2,724	823
Free Cash Flow	523	205	-404	-2,058	-3,071
Free Cash Flow Growth	155.12%	-	-	-	-
Free Cash Flow Margin	8.18%	3.26%	-6.60%	-40.83%	-27.18%
Free Cash Flow Per Share	10.41	4.08	-8.53	-47.20	-70.58
Cash Interest Paid	5	8	8	10	6
Cash Income Tax Paid	34	30	-	23	1,030
Levered Free Cash Flow	368.75	-328.25	470.25	721	-656.63
Unlevered Free Cash Flow	371.88	-323.25	475.25	727.25	-652.88
Change in Working Capital	-86	-864	917	3,065	4,978

Source: S&P Global Market Intelligence. Standard template. Financial Sources.